Teleflex (TFX) Projected to Post Quarterly Earnings on Thursday

Teleflex (NYSE:TFX) is expected to post its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Teleflex to post earnings of $3.86 per share and revenue of $813.24 million for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Teleflex Price Performance

Teleflex stock opened at $177.45 on Tuesday. The firm has a market cap of $8.24 billion, a PE ratio of 35.28, a price-to-earnings-growth ratio of 1.73 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock’s fifty day moving average price is $176.98 and its two-hundred day moving average price is $207.11. Teleflex has a one year low of $165.62 and a one year high of $249.90.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on TFX. Truist Financial dropped their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Royal Bank of Canada dropped their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Finally, Mizuho dropped their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $246.00.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.